What is prognosis of Urticaria?

Lalela leli khasi

Siyini isibikezelo se-urticaria?

Isibikezelo se-urticaria, eyaziwa nangokuthi i-hives, siyahlukahluka kuye ngohlobo nembangela yesimo.

I-urticaria ebucayi, ehlala isikhathi esingaphansi kwamasonto ayisithupha, ngokuvamile ine-prognosis enhle kakhulu, izimo eziningi ziphela kungakapheli amahora angu-24 futhi izikhathi ezingavamile ziphinde zenzeke.

I-urticaria engapheli, ehlala isikhathi esingaphezu kwamasonto ayisithupha, ine-prognosis evikelekile futhi incike esifweni esihambisanayo esibangela i-urticaria, kanye nokuphendula ekwelapheni.

Ukuqagela i-urticaria engapheli kunzima ukubikezela, njengoba ezinye iziguli zingase zithole ukukhululeka, kuyilapho ezinye zingase zibe nenkambo eqhubekayo noma ephindaphindwayo.

Ukuqagela kuvame ukuba kuhle, kodwa kwezinye izimo, kungase kuthonywe isimo somzimba esiyisisekelo noma ukuba khona kwezifo ezithathelwanayo.

Kubalulekile ukuba iziguli zisebenzisane eduze nomhlinzeki wazo wezokunakekelwa kwempilo ukuphatha isimo sazo nokuqapha izimpawu zazo ukuze kutholakale umphumela omuhle kakhulu.

Izikhombo

PubMed/Medline https://www.nlm.nih.gov/databases/download/pubmed_medline.html

RefinedWeb https://arxiv.org/abs/2306.01116

Leaf FA, Jaecks EP, Rodriguez DR: Bullous urticaria pigmentosa. Cutis. 1996, 58 (5): 358-60.

Lewis HM, Winter E, Darbyshire P, Yoong A, Marsden JR, Moss C: Urticaria pigmentosa and acute lymphoblastic leukaemia. J R Soc Med. 1995, 88 (9): 530P-531P.

Haas N, Birkle-Berlinger W, Henz BM: Prognosis of acute urticaria in children. Acta Derm Venereol. 2005, 85 (1): 74-5.

Botto NC, Warshaw EM: Solar urticaria. J Am Acad Dermatol. 2008, 59 (6): 909-20; quiz 921-2.

Greiwe J, Bernstein JA: Approach to the Patient with Hives. Med Clin North Am. 2020, 104 (1): 15-24.

Engstrom J, Neher JO, St Anna L: Clinical Inquiry. What is the prognosis for patients with chronic urticaria? J Fam Pract. 2011, 60 (3): 168a-b.

Tanaka T, Hiragun M, Hide M, Hiragun T: [ANALYSIS OF PRIMARY TREATMENT AND PROGNOSIS OF SPONTANEOUS URTICARIA IN A LOCAL CLINIC OF OFFICE DERMATOLOGY]. Arerugi. 2015, 64 (9): 1261-8.

Ukuzikhulula: kwezokwelapha

Le webhusayithi inikezwa ngezinjongo zemfundo nezokwaziswa kuphela futhi ayifaki ukunikeza izeluleko zezokwelapha noma izinsizakalo zobungcweti.

Imininingwane enikeziwe akufanele isetshenziselwe ukuxilonga noma ukwelapha inkinga noma isifo, futhi labo abafuna iseluleko somuntu siqu sezokwelapha kufanele babonane nodokotela onelayisense.

Sicela uqaphele ukuthi inethiwekhi ye-neural ekhiqiza izimpendulo zemibuzo, ayinembile ngokukhethekile uma kuziwa kokuqukethwe kwezinombolo. Ngokwesibonelo, inani labantu abanesifo esithile.

Ngaso sonke isikhathi funa iseluleko sikadokotela wakho noma omunye umhlinzeki wezempilo ofanelekayo mayelana nesimo sezokwelapha. Ungalokothi ungayinaki iseluleko sezokwelapha sobungcweti noma ubambezele ukusifuna ngenxa yento oyifundile kule webhusayithi. Uma ucabanga ukuthi ungase ube nesimo esiphuthumayo sezokwelapha, shayela i-911 noma uye egumbini lezimo eziphuthumayo eliseduze ngokushesha. Ayikho ubudlelwano bokuthi udokotela-isiguli obakhiwe yile webhusayithi noma ukusetshenziswa kwayo. I-BioMedLib noma abasebenzi bayo, noma noma yimuphi umnikeli wale webhusayithi, akenzi noma yimiphi imibono, ecacile noma ecacile, mayelana nolwazi olunikezwe lapha noma ukusetshenziswa kwayo.

Ukuzikhulula: amalungelo obunikazi

I-Digital Millennium Copyright Act ka-1998, i-17 U.S.C. § 512 (i- DMCA) inikeza indlela yokuphendula kubanikazi bamalungelo obunikazi abakholelwa ukuthi okokusebenza okubonakala kwi-Internet kwephula amalungelo abo ngaphansi komthetho we-copyright wase-US.

Uma ukholelwa ngobuqotho ukuthi noma yikuphi okuqukethwe noma okokusebenza okwenziwe kutholakale maqondana newebhusayithi yethu noma izinsizakalo kwephula ilungelo lakho lobunikazi, wena (noma umenzeli wakho) ungasithumela isaziso esicela ukuthi okuqukethwe noma okokusebenza kususwe, noma ukufinyelela kukho kuvinjelwe.

Izaziso kufanele zithunyelwe ngokubhala nge-imeyili (bheka isigaba esithi "Contact" ukuze uthole ikheli le-imeyili).

I-DMCA idinga ukuthi isaziso sakho sokwephulwa kwamalungelo obunikazi kubandakanye imininingwane elandelayo: (1) incazelo yomsebenzi onamalungelo obunikazi oyisihloko sokwephulwa okusolwa; (2) incazelo yokuqukethwe okusolwa ukwephula amalungelo obunikazi nolwazi olwanele ukusivumela ukuthi sithole okuqukethwe; (3) imininingwane yokuxhumana nawe, kufaka phakathi ikheli lakho, inombolo yocingo nekheli le-imeyili; (4) isitatimende sakho sokuthi unokholo oluhle lokuthi okuqukethwe ngendlela ekhonjiwe ngayo akugunyaziwe ngumnikazi wamalungelo obunikazi, noma umenzeli wakhe, noma ngokusebenza kwanoma imuphi umthetho;

(5) isitatimende sakho, esisayinwe ngaphansi kwesijeziso sokufakaza amanga, sokuthi ukwaziswa okusesazisweni kunembile nokuthi unegunya lokuphoqelela amalungelo obunikazi okuthiwa aphuliwe;

futhi (6) isignesha ebonakalayo noma ye-elekthronikhi yomnikazi we-copyright noma umuntu ogunyaziwe ukuba asebenze egameni lomnikazi we-copyright.

Ukwehluleka ukufaka yonke imininingwane engenhla kungaholela ekubambezelweni kokucutshungulwa kwesikhalazo sakho.

Othintana naye

Sicela usithumelele i-imeyili nganoma yimiphi imibuzo / iziphakamiso.

What is prognosis of urticaria?

The prognosis of urticaria, also known as hives, varies depending on the type and cause of the condition.

Acute urticaria, which lasts less than six weeks, generally has an excellent prognosis, with most cases resolving within 24 hours and episodes rarely recurring.

Chronic urticaria, which lasts more than six weeks, has a more guarded prognosis and depends on the comorbid disease causing the urticaria, as well as the response to therapy.

The prognosis in chronic urticaria is more difficult to predict, as some patients may experience remission, while others may have a persistent or recurrent course.

The prognosis is generally favorable, but in some cases, it may be affected by the underlying medical condition or the presence of autoimmune disorders.

It is important for patients to work closely with their healthcare provider to manage their condition and monitor their symptoms for the best possible outcome.

Disclaimer: medical

This web site is provided for educational and informational purposes only and does not constitute providing medical advice or professional services.

The information provided should not be used for diagnosing or treating a health problem or disease, and those seeking personal medical advice should consult with a licensed physician.

Please note the neural net that generates answers to the questions, is specially inaccurate when it comes to numeric content. For example, the number of people diagnosed with a specific disease.

Always seek the advice of your doctor or other qualified health provider regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. If you think you may have a medical emergency, call 911 or go to the nearest emergency room immediately. No physician-patient relationship is created by this web site or its use. Neither BioMedLib nor its employees, nor any contributor to this web site, makes any representations, express or implied, with respect to the information provided herein or to its use.

Disclaimer: copyright

The Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (the “DMCA”) provides recourse for copyright owners who believe that material appearing on the Internet infringes their rights under U.S. copyright law. If you believe in good faith that any content or material made available in connection with our website or services infringes your copyright, you (or your agent) may send us a notice requesting that the content or material be removed, or access to it blocked. Notices must be sent in writing by email (see 'Contact' section for email address) . The DMCA requires that your notice of alleged copyright infringement include the following information: (1) description of the copyrighted work that is the subject of claimed infringement; (2) description of the alleged infringing content and information sufficient to permit us to locate the content; (3) contact information for you, including your address, telephone number and email address; (4) a statement by you that you have a good faith belief that the content in the manner complained of is not authorized by the copyright owner, or its agent, or by the operation of any law; (5) a statement by you, signed under penalty of perjury, that the information in the notification is accurate and that you have the authority to enforce the copyrights that are claimed to be infringed; and (6) a physical or electronic signature of the copyright owner or a person authorized to act on the copyright owner’s behalf. Failure to include all of the above information may result in the delay of the processing of your complaint.